Biotech

All Articles

Charles Baum takes control of Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., that supervised Mirati Therapies' $ 5.8 billion purchase to Bristol Myer...

Asarina to shut after efforts to companion Tourette's medication fail

.After connecting to more than 200 providers to companion a Tourette disorder therapy that revealed ...

Novartis pens $150M ahead of time bispecifics manage Dren Bio

.Novartis has had some misfortune with bispecific antitoxins previously, but determining by the phar...

AstraZeneca vegetations an EGFR plant with Pinetree package worth $45M

.Pinetree Therapeutics will certainly aid AstraZeneca plant some plants in its own pipeline along wi...

GRO rounds up $60M series B to take gout arthritis therapy into center

.GRO Biosciences has actually finished the full week with an additional $60.3 million in the banking...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava sheds CEO

.Accept to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings ...